Literature DB >> 12847396

Heliox does not affect gas exchange during high-frequency oscillatory ventilation if tidal volume is held constant.

Andrew L Katz1, Michael A Gentile, Damian M Craig, George Quick, Ira M Cheifetz.   

Abstract

OBJECTIVE: To compare gas exchange with heliox and oxygen-enriched air during high-frequency oscillatory ventilation, while controlling for tidal volume, in a pediatric swine model of acute lung injury. We hypothesized that when tidal volume delivery is held constant, heliox does not alter gas exchange.
DESIGN: Randomized, crossover trial.
SETTING: University animal research laboratory.
SUBJECTS: Ten swine (4.4-5.4 kg).
INTERVENTIONS: Acute lung injury (A-a gradient of >300 mm Hg) was created using repeated saline lavage during conventional mechanical ventilation. The animals were then administered high-frequency oscillatory ventilation and ventilated with 60% oxygen/40% helium and 60% oxygen/40% nitrogen in a randomized, crossover trial. When changing gas mixtures within each animal, mean airway pressure (Paw = 16.8 +/- 0.3 cm H(2)O) and frequency (10 Hz) were held constant. Oscillation amplitude (DeltaP) was adjusted to maintain constant tidal volume delivery as measured by respiratory inductive plethysmography. Next, the animals were ventilated with 40% oxygen/60% helium and 40% oxygen/60% nitrogen in a randomized crossover trial, again controlling for tidal volume.
MEASUREMENTS AND MAIN RESULTS: Gas exchange was assessed by arterial blood gas analysis after ventilation with each gas mixture. We demonstrated no significant difference in Paco(2) or Pao(2) between the heliox and oxygen-enriched air with either the 40% or 60% oxygen mixtures. The oscillation amplitude required to achieve the same tidal volume delivery was significantly less with heliox.
CONCLUSIONS: We conclude that if tidal volume delivery is maintained constant, heliox does not alter gas exchange when compared with oxygen-enriched air. However, to achieve the same tidal volume delivery, a lower oscillation amplitude is required with heliox. The clinical benefit of heliox administration during high-frequency oscillatory ventilation has yet to be determined. Possible advantages of heliox include improved ventilation of larger patients when approaching the power limitations of the Sensormedics 3100A oscillator and a potential reduction in the oscillation amplitude delivered to the more proximal gas exchange units.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12847396     DOI: 10.1097/01.CCM.0000070584.00490.7B

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

Review 1.  Heliox for croup in children.

Authors:  Irene Moraa; Nancy Sturman; Treasure M McGuire; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2021-08-16

2.  Effects of heliox as carrier gas on ventilation and oxygenation in an animal model of piston-type HFOV: a crossover experimental study.

Authors:  Bakhtiyar Zeynalov; Takehiko Hiroma; Tomohiko Nakamura
Journal:  Biomed Eng Online       Date:  2010-11-12       Impact factor: 2.819

3.  Heliox allows for lower minute volume ventilation in an animal model of ventilator-induced lung injury.

Authors:  Charlotte J Beurskens; Hamid Aslami; Friso M de Beer; Margreeth B Vroom; Benedikt Preckel; Janneke Horn; Nicole P Juffermans
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

4.  Extremely low flow tracheal gas insufflation of helium-oxygen mixture improves gas exchange in a rabbit model of piston-type high-frequency oscillatory ventilation.

Authors:  Atsushi Baba; Tomohiko Nakamura; Tetsuya Aikawa; Kenichi Koike
Journal:  Biomed Eng Online       Date:  2013-04-08       Impact factor: 2.819

5.  Heliox for croup in children.

Authors:  Irene Moraa; Nancy Sturman; Treasure M McGuire; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29

6.  Mechanical ventilation with heliox in an animal model of acute respiratory distress syndrome.

Authors:  Charlotte J Beurskens; Hamid Aslami; Friso M de Beer; Joris Jth Roelofs; Margreeth B Vroom; Nicole P Juffermans
Journal:  Intensive Care Med Exp       Date:  2014-02-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.